Inventor · disambiguated record
Hidenori Ichijo
Also filed as: ICHIJO HIDENORI
9 granted patents·2 pending applications·167 citations·filing 1991–2017
89Inventor score
Files withLUDWIG INST CANCER RES4CREATIVE BIOMOLECULES INC2TAKEDA PHARMACEUTICAL2JAPAN FOUND CANCER1OSAKA IND PROMOTION ORG1
Top patents by PatentIndex Score
11 records- 0187US5229495ASubstantially pure receptor like TGF-β 1 binding molecules and uses thereofLUDWIG INST CANCER RES·Filed 1991·Granted Jul 20, 1993·64 cites·5 claims
- 0275US5928940AMorphogen-responsive signal transducer and methods of use thereofCREATIVE BIOMOLECULES INC·Filed 1996·Granted Jul 27, 1999·31 cites·29 claims
- 0372US5968752AMethod for identifying an OP-1 analog which binds an ALK-1 receptorCREATIVE BIOMOLECULES INC·Filed 1996·Granted Oct 19, 1999·27 cites·3 claims
- 0472US5731200AIsolated nucleic acid encoding receptor-like TGF-β1 binding proteinLUDWIG INST CANCER RES·Filed 1995·Granted Mar 24, 1998·18 cites·8 claims
- 0564US7390625B2Apoptosis-associated protein and use thereofTAKEDA PHARMACEUTICAL·Filed 2003·Granted Jun 24, 2008·2 cites·10 claims
- 0658US5578703ASubstantially pure receptor like TFG-β1 binding moleculesLUDWIG INST CANCER RES·Filed 1992·Granted Nov 26, 1996·14 cites·2 claims
- 0754US6194187B1Apoptosis-inducing protein and gene encoding the sameJAPAN FOUND CANCER·Filed 1997·Granted Feb 27, 2001·10 cites·25 claims
- 0842US2007167386A1Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the sameOSAKA IND PROMOTION ORG·Filed 2004·Application pending·0 cites
- 0937US2008131370A1Screening MethodTAKEDA PHARMACEUTICAL·Filed 2005·Application pending·0 cites
- 1033US10689394B2Thieno[2,3-b]pyridine derivative, quinoline derivative, and use thereofUNIV TOKYO·Filed 2017·Granted Jun 23, 2020·0 cites·18 claims
- 1124US6030795ARecombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein productionLUDWIG INST CANCER RES·Filed 1996·Granted Feb 29, 2000·1 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →